Department of Internal Medicine, Yonsei University College of Medicine, Seoul 120-752, Korea.
Yonsei Med J. 2012 Sep;53(5):1022-7. doi: 10.3349/ymj.2012.53.5.1022.
Pharmacovigilance Research Network built a spontaneous reporting system and collected adverse drug reactions (ADRs) by electronic submission (e-sub) in Korea. We analyzed ADRs spontaneously reported through e-sub from regional health professionals.
Nine hundred and thirty three ADR cases were collected and analyzed from January to December in 2008. "A matter" was defined as one symptom matched to one culprit drug included in an ADR case. We collected and analyzed e-sub ADR cases and matters to determine common culprits and organ specified ADR matters.
There were 3,049 matters in 933 ADR cases for 1 year, and 3.3 matters per case were reported. In organ specific ADR classification, skin reactions which took the first place in 866 matters (28%) included urticaria and rash. The next cases were neurologic symptom (624 matters, 21%) and gastrointestinal symptom (581 matters, 19%). Doctor (53%) and pharmacist (31%) were the most important participants in e-sub spontaneous reporting system, and 3% of ADR cases were reported by patients or their guardians. WHO-Uppsala Monitoring Center causality assessment results showed certain 10.6%, probable 37.7%, possible 41.7% and below unlikely 10.0%. Culprit drugs were antibiotics (23.4%), neurologic agents (14.7%) and non-steroidal anti-inflammatory drugs (9.4%).
In our study, antibiotic was most common culprit drug, and skin manifestation was most common symptom in e-sub ADRs collected from regional healthcare practitioners in Korea.
药物警戒研究网络建立了一个自发报告系统,并通过电子提交(e-sub)在韩国收集药物不良反应(ADR)。我们分析了由区域卫生专业人员自发报告的通过 e-sub 报告的 ADR。
2008 年 1 月至 12 月期间,共收集和分析了 933 例 ADR 病例。“一个事项”被定义为一个症状与一个包含在 ADR 病例中的可疑药物相匹配。我们收集和分析了 e-sub ADR 病例和事项,以确定常见的可疑药物和特定器官的 ADR 事项。
在 933 例 ADR 病例中,1 年内共报告了 3049 项事项,每例报告 3.3 项。在器官特异性 ADR 分类中,皮肤反应(866 项,占 28%)位居首位,包括荨麻疹和皮疹。其次是神经症状(624 项,占 21%)和胃肠道症状(581 项,占 19%)。医生(53%)和药剂师(31%)是 e-sub 自发报告系统中最重要的参与者,3%的 ADR 病例是由患者或其监护人报告的。世界卫生组织-乌普萨拉监测中心因果关系评估结果显示,肯定的占 10.6%,很可能的占 37.7%,可能的占 41.7%,不太可能的占 10.0%。可疑药物是抗生素(23.4%)、神经药物(14.7%)和非甾体抗炎药(9.4%)。
在我们的研究中,抗生素是最常见的可疑药物,皮肤表现是韩国区域医疗保健从业人员收集的 e-sub ADR 中最常见的症状。